SUMMARY Echocardiography was performed in 60 people with tuberous sclerosis to ascertain the prevalence and course of cardiac rhabdomyomata at different ages. Twenty five (58%) of 43 children had tumours, but only three (18%) of 17 adults. The tumours tended to remain the same size through childhood. Only three infants were included but evidence from this and some published case reports suggest that the tumours tend to regress in early infancy and again in adolescence. The prevalence of tumours in young infants with tuberous sclerosis is likely to be considerably above 50%. As other signs of tuberous sclerosis are usually absent at this age echocardiography may afford the most useful diagnostic test in early infancy.
It has been known for many years that people with tuberous sclerosis may have cardiac rhabdomyomata as part of the syndrome, but assessment of the prevalence of the tumours has depended in the past largely on necropsy studies. These studies have suggested a high mortality from rhabdomyomata in the first few years of life with 78% of deaths in the first year. It has been said that 37-50% of these deaths are associated with tuberous sclerosis but this is probably an underestimate as other diagnostic features of tuberous sclerosis may not appear until later childhood.1 2 Conversely, necropsy studies in people known to have tuberous sclerosis have suggested up to 30% with rhabdomyomatal but these figures may also be biased.
Two dimensional echocardiography offers a simple non-invasive method that shows cardiac tumours very well, and two small studies have found cardiac tumours in eight of 16 and seven of 11 people with tuberous sclerosis respectively.3 4 The present study was carried out in the hope of assessing the prevalence of these tumours at different ages and also because of the impression that some tumours may regress.
Methods
Patients with tuberous sclerosis and their families were Thirty seven first degree relatives (33 adults and four children) were examined. None had any skin manifestations or symptoms of tuberous sclerosis. No cardiac tumours were found in the adults but one infant had two 8 mm tumours in the left ventricle. Table 1 shows the prevalence of tumours at different ages. There was no significant difference in the prevalence of tumours through childhood, but children under 16 years were significantly more likely to have tumours than adults (25 of 43 children but only three of 17 adults; X2=8 02, p<OO1). Table   2 shows that the mean number of tumours per person in those who have them did not seem to vary significantly at different ages.
The mean diameter of tumours in those who had any was assessed by taking the mean of two largest dimensions for each tumour and averaging these for the age groups. Table 2 shows no significant difference between the absolute sizes of the tumours at different ages, although the trend is for diminution with increasing age. As the linear dimensions of the cardiac chambers of an adult are almost twice those of a child of 2 years there is clearly a relative diminution in tumour size.
In most cases the tumours were easily seen (fig 1) , though in a few they were found only after a careful search. Many tumours were highly reflectile, but a few undoubted tumours did not seem very different from adjacent myocardium; we feel that the difference may be related to maturation (see below). Some quite reflectile tumours, however, were seen in older children and adults. Some reflectile areas are commonly seen in normal myocardium and these need to be distinguished from small intramural We have found no information on the course of tumours in adolescence, though there is a case report of an asymptomatic childhood rhabdomyoma whose size remained unchanged over a period of three years.8 There are case reports, however, of 12 infants later shown to have tuberous sclerosis-all in fact under 2 months old when first seen-who had a later review"15; in 11 of these the tumours regressed or even disappeared, while in one the tumours were the same size 18 months later.15 Unfortunately our series included only three infants but regression occurred in all of them. It seems likely, therefore, that regression is the usual course not only in early adult life but also in infancy, and that the prevalence of tumours in neonates is higher than the 50% seen in older children.
This has important implications for management of symptomatic tumours. Obstructive symptoms or arrhythmias due to a rhabdomyoma in tuberous sclerosis are rare, and did not occur in our series, but some authors have proposed urgent surgery for symptomatic cardiac tumours despite the high mortality.8 The chances of tumour regression or relative lack of growth, however, suggest a conservative approach.10 12 The boy in this series referred to in figs 2-6 developed a murmur suggesting subaortic stenosis, but he remained quite well and the murmur disappeared as the tumour regressed.
As far as the question of whether an infant or fetus with a cardiac tumour will turn out to have tuberous sclerosis is concerned, the quoted risk of 50%2 is probably an underestimate as it derives from postmortem studies particularly in neonates in whom the diagnosis of tuberous sclerosis may be difficult to establish. It seems very probable that nearly all multiple tumours are rhabdomyomata and nearly all these are due to tuberous sclerosis.16 A total of 25% were single in our series but as rhabdomyomata are by far the commonest tumour in infancy then even a single tumour found incidentally by echocardiography is in the absence of other clues also likely to be a rhabdomyoma and probably due to tuberous sclerosis.
The lack of changes in the skin or on computed tomography in an infant with cardiac tumours should not lead to false reassurance. Although cardiac tumours have not been described as a sole manifestation of tuberous sclerosis in adults,17 three infants in this study had no other signs of tuberous sclerosis at presentation, though they appeared later in two of the three. We have found published reports of six neonates with cardiac tumours and later signs of tuberous sclerosis in whom pale spots were mentioned; the spots appeared before the age of 5 months in only one baby.'0 11 15 18 19 In the screening of adult relatives the value of cardiac ultrasound is clearly less than in infancy: in the present series tumours were not found in the apparently unaffected relatives and were relatively infrequent in even affected adults. In childhood and particularly in infants, however, cardiac ultrasound may well be helpful because of the higher prevalence of tumours; it would, for example, be particularly helpful in babies who present with infantile spasms, but who have not yet developed any aetiological evidence, so as to allow early diagnosis and appropriate family genetic advice for some of the 25% who eventually show features of tuberous sclerosis. 20 Echocardiography, when indicated, should not be delayed, lest the tumours regress. Fetal echocardiography also seems likely to afford a reasonable yield where there is a relevant family history, particularly if the prevalence in infants should prove to be high. 10 1 15 18 19 We are most grateful to the parents and children who took part in the study, to Dr EM Carr-Saunders for data on one family, and to many other paediatricians and family doctors. In particular we thank Mrs Ann Hunt and the Tuberous Sclerosis Association for much help, encouragement, and financial support. 
